IMUX Stock Price
Immunic, Inc.
IMUX stock price is $7.45 (-2.42% on the day), giving Immunic, Inc. a market cap of $104.11M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
IMUX Stock Overview
- Price
- $7.45
- Previous close
- $7.63
- Open
- $7.65
- Market cap
- $104.11M
- P/E ratio
- -1.1
- 52-week range
- $5.06 - $17.43
- 1-year price target
- $43.09
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 30
About Immunic, Inc.
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMUX | $7.45 | -2.4% | 203.31K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |